Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is 3.33% higher on its value in year-to-date trading and has touched a low of $11.55 and a high of $17.99 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CPRX stock was last observed hovering at around $17.51 in the last trading session, with the day’s loss setting it -0.14%.
Currently trading at $17.37, the stock is 7.40% and 8.56% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.1 million and changing -0.80% at the moment leaves the stock 16.16% off its SMA200. CPRX registered 29.53% gain for a year compared to 6-month gain of 18.97%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 14.65% loss in the last 1 month and extending the period to 3 months gives it a 14.88%, and is 3.89% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.24% over the week and 2.96% over the month.
Catalyst Pharmaceuticals Inc (CPRX) has around 167 employees, a market worth around $2.05B and $411.35M in sales. Current P/E ratio is 32.26 and Fwd P/E is 13.68. Profit margin for the company is 15.83%. Distance from 52-week low is 50.39% and -3.45% from its 52-week high. The company has generated returns on investments over the last 12 months (11.54%).
The EPS is expected to grow by 50.79% this year
The shares outstanding are 107.12M, and float is at 101.65M with Short Float at 5.26%.
Catalyst Pharmaceuticals Inc (CPRX) Insider Activity
The most recent transaction is an insider sale by Del Carmen Jeffrey, the company’s Chief Commercial Officer. SEC filings show that Del Carmen Jeffrey sold 7,541 shares of the company’s common stock on Jun 07 ’24 at a price of $16.07 per share for a total of $0.12 million. Following the sale, the insider now owns 18427.0 shares.
Catalyst Pharmaceuticals Inc disclosed in a document filed with the SEC on Jun 05 ’24 that INGENITO GARY (Chief Med. & Reg. Officer) sold a total of 80,000 shares of the company’s common stock. The trade occurred on Jun 05 ’24 and was made at $16.16 per share for $1.29 million. Following the transaction, the insider now directly holds 51391.0 shares of the CPRX stock.
Still, SEC filings show that on Jun 04 ’24, Daly Richard J (President and CEO) disposed off 17,323 shares at an average price of $15.97 for $0.28 million. The insider now directly holds 234,824 shares of Catalyst Pharmaceuticals Inc (CPRX).
